These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19629994)
21. Detection of glutathione in the human brain in vivo by means of double quantum coherence filtering. Trabesinger AH; Weber OM; Duc CO; Boesiger P Magn Reson Med; 1999 Aug; 42(2):283-9. PubMed ID: 10440953 [TBL] [Abstract][Full Text] [Related]
22. Computation of brain metabolite ratios in single-voxel proton MR spectroscopy: comparison between semiautomatic and automatic software. Mazzoni LN; Belli G; Ginestroni A; Pratesi A; Agnoloni S; Diciotti S; Mascalchi M Radiol Med; 2010 Feb; 115(1):125-32. PubMed ID: 19562268 [TBL] [Abstract][Full Text] [Related]
24. The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques. Jírů F; Dezortová M; Burian M; Hájek M MAGMA; 2003 Nov; 16(3):135-43. PubMed ID: 14564645 [TBL] [Abstract][Full Text] [Related]
25. In vivo T(2) relaxation time measurement with echo-time averaging. Prescot AP; Shi X; Choi C; Renshaw PF NMR Biomed; 2014 Aug; 27(8):863-9. PubMed ID: 24865447 [TBL] [Abstract][Full Text] [Related]
26. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961 [TBL] [Abstract][Full Text] [Related]
27. The age dependence of T2 relaxation times of N-acetyl aspartate, creatine and choline in the human brain at 3 and 4T. Jiru F; Skoch A; Wagnerova D; Dezortova M; Viskova J; Profant O; Syka J; Hajek M NMR Biomed; 2016 Mar; 29(3):284-92. PubMed ID: 26752593 [TBL] [Abstract][Full Text] [Related]
28. Fast mapping of the T2 relaxation time of cerebral metabolites using proton echo-planar spectroscopic imaging (PEPSI). Tsai SY; Posse S; Lin YR; Ko CW; Otazo R; Chung HW; Lin FH Magn Reson Med; 2007 May; 57(5):859-65. PubMed ID: 17457864 [TBL] [Abstract][Full Text] [Related]
30. HERMES: Hadamard encoding and reconstruction of MEGA-edited spectroscopy. Chan KL; Puts NA; Schär M; Barker PB; Edden RA Magn Reson Med; 2016 Jul; 76(1):11-9. PubMed ID: 27089868 [TBL] [Abstract][Full Text] [Related]
31. Neurochemical evaluation of brain function with 1H magnetic resonance spectroscopy in patients with fragile X syndrome. Utine GE; Akpınar B; Arslan U; Kiper PÖ; Volkan-Salancı B; Alanay Y; Aktaş D; Haliloğlu G; Oğuz KK; Boduroğlu K; Alikaşifoğlu M Am J Med Genet A; 2014 Jan; 164A(1):99-105. PubMed ID: 24259304 [TBL] [Abstract][Full Text] [Related]
32. In vivo relaxation of N-acetyl-aspartate, creatine plus phosphocreatine, and choline containing compounds during the course of brain infarction: a proton MRS study. Gideon P; Henriksen O Magn Reson Imaging; 1992; 10(6):983-8. PubMed ID: 1461096 [TBL] [Abstract][Full Text] [Related]
33. N-Acetylaspartate concentrations in the thalami of neuropathic pain patients and healthy comparison subjects measured with (1)H-MRS. Fukui S; Matsuno M; Inubushi T; Nosaka S Magn Reson Imaging; 2006 Jan; 24(1):75-9. PubMed ID: 16410181 [TBL] [Abstract][Full Text] [Related]
34. Quantitative 1H MRS of the human brain in vivo based on the stimulation phantom calibration strategy. Duc CO; Weber OM; Trabesinger AH; Meier D; Boesiger P Magn Reson Med; 1998 Mar; 39(3):491-6. PubMed ID: 9498606 [TBL] [Abstract][Full Text] [Related]
35. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. Castillo M; Green C; Kwock L; Smith K; Wilson D; Schiro S; Greenwood R AJNR Am J Neuroradiol; 1995 Jan; 16(1):141-7. PubMed ID: 7900583 [TBL] [Abstract][Full Text] [Related]
36. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance? Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912 [TBL] [Abstract][Full Text] [Related]
37. Contribution of reduced and oxidized glutathione to signals detected by magnetic resonance spectroscopy as indicators of local brain redox state. Satoh T; Yoshioka Y Neurosci Res; 2006 May; 55(1):34-9. PubMed ID: 16503064 [TBL] [Abstract][Full Text] [Related]
38. Reproducibility of 3D proton spectroscopy in the human brain. Li BS; Babb JS; Soher BJ; Maudsley AA; Gonen O Magn Reson Med; 2002 Mar; 47(3):439-46. PubMed ID: 11870829 [TBL] [Abstract][Full Text] [Related]
39. In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Edden RA; Pomper MG; Barker PB Magn Reson Med; 2007 Jun; 57(6):977-82. PubMed ID: 17534922 [TBL] [Abstract][Full Text] [Related]
40. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]